Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 26, 2025Brain CommunicationsOpen Access

Five-year disease-modifying therapeutic experience of 102 Chinese pediatric 5q-spinal muscular atrophy: a retrospective analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

MJMinyan JiangCLCuili LiangYZYani Zhang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jiang et al. (2025) studied this question.

synapsesocial.com/papers/694035fb2d562116f29095fahttps://doi.org/10.1093/braincomms/fcaf453
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Five-year disease-modifying therapeutic experience of 102 Chinese pediatric 5q-spinal muscular atrophy: a retrospective analysis2025
  2. 2Clinical and motor functional evaluation of patients with bi-allelic disease-causing variants in SMN1 gene and two copies of SMN2 treated in the pre-symptomatic stage2024
  3. 3Evaluating Therapeutic Outcomes in Spinal Muscular Atrophy: An Indian Experience2025
  4. 4Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 20162024 · 14 citations
  5. 5Disease characteristics and treatment status of genetically confirmed spinal muscular atrophy patients: a cross-sectional survey in China2025